World Diabetes Day 2023 – What innovations are being developed for diabetes?

What innovations are being developed for diabetes?

With 1 in 10 people living with Diabetes globally (537 million), and this is expected to rise to 643 million by 2030 and 783 million by 2045[i], finding new ways of preventing, diagnosing, and treating the disease is crucial.  To celebrate World Diabetes Day 2023 we take a look at what innovations are being developed in the Health Technology sector relating to diabetes. To do this we initially ran a simple search on diabetes and isolated the search to the last five years publications only.

During this time, there have been almost 300k patent publications relating to Diabetes. As Figure 1 shows the patents are in a variety of classifications. However, almost a quarter of the publications relate to classification codes A61B5/145[ii] (Measuring Characteristics of Blood in Vito) and A61B5/00[iii] (Measuring for Diagnostic Purposes) and we will look at the innovators in this space and highlight a few of their patents.

Who are the main players in Diabetes Monitoring?

Figure 2 shows Roche, Dexcom, and Medtronic dominate, and we will showcase some of their recent patents.

Roche Diagnostics – Patent number US2020250939A1 MEDICAL DEVICE ALERT, OPTIMIZATION, PERSONALIZATION, AND ESCALATION

Figure 3 – Patent number US2020250939A1

This patent alerts the user via a message sent to their watch, smartphone, smart speaker, etc that their glucose levels have changed. The alerts will get progressively louder/stronger until the user acknowledges the message.

Dexcom – Patent number US2023138673A1 – RANKING FEEDBACK FOR IMPROVING DIABETES MANAGEMENT

This patent is a method for providing feedback based on glucose measurements. Readings are taken and analysed against historical data with alerts sent to the wearer advising if readings are higher/lower than normal at periodic times. Ways to make improvements are suggested if particular actions are taken, ie exercise activity.

Medtronic – Patent US2022143314A1 – DIABETES THERAPY BASED ON DETERMINATION OF FOOD ITEM

This patent by Medtronic discloses a method for adapting diabetes therapy based on what a person eats. Using a mixture of wearable devices and cameras, information is generated allowing therapy to be tailored to the individual based on their diet.

[i] https://worlddiabetesday.org/about/facts-figures/

[ii] A61B5/145:

Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; {Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue}(measuring of blood pressure or blood flow A61B5/02; non-radiation detecting or locating of foreign bodies in blood A61B5/06)

[iii] A61B5/00:

Measuring for diagnostic purposes (radiation diagnosis A61B6/00; diagnosis by ultrasonic, sonic or infrasonic waves A61B8/00); Identification of persons

Are you developing new inventions around Diabetes?

At PatWorld, we understand the importance of protecting your #HealthTech inventions, and we can provide our clients with accurate, reliable, and cost-effective information and services tailored to meet individual needs.

For further information on our searches please visit our search options page Patent Search | Non-Patent Search | All Technologies (patworld.com).

If you enjoy our content here, you’ll love the stuff we share on LinkedIn, follow us now. Not on LinkedIn?  Check out our other social media sites:

Twitter PatWorld Patent Database & Search Service (@PatWorlddata) / Twitter

Facebook PatWorld Patent Intelligence Platform & Research Services | Newport | Facebook

Instagram https://www.instagram.com/patworld__database/